GIANT CELL ARTERITIS
Clinical trials for GIANT CELL ARTERITIS explained in plain language.
Never miss a new study
Get alerted when new GIANT CELL ARTERITIS trials appear
Sign up with your email to follow new studies for GIANT CELL ARTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for giant cell arteritis patients?
Disease control Recruiting nowThis study tests whether the drug abatacept can help people with giant cell arteritis, a condition that causes inflammation in blood vessels. About 78 adults with newly diagnosed or relapsing disease will receive either abatacept or a placebo for up to 12 months. The goal is to s…
Matched conditions: GIANT CELL ARTERITIS
Phase: PHASE3 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
Could a quicker MRI spot a dangerous artery disease?
Diagnosis Recruiting nowThis study looks at whether a lower-resolution MRI can reliably detect giant cell arteritis, a condition that inflames arteries and can cause blindness or stroke if not treated quickly. Researchers will compare different MRI scans in 133 adults suspected of having the disease. If…
Matched conditions: GIANT CELL ARTERITIS
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Diagnosis
Last updated Jun 12, 2026 12:04 UTC
-
New PET scan could spot hidden artery inflammation faster
Diagnosis Recruiting nowThis study tests whether a new imaging agent called AzaFol, used with a PET/CT scan, can improve diagnosis of giant cell arteritis (GCA), a condition where blood vessels become inflamed. About 70 adults aged 50 and older with suspected GCA will receive one AzaFol-PET/CT scan. The…
Matched conditions: GIANT CELL ARTERITIS
Phase: PHASE2 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Diagnosis
Last updated Jun 10, 2026 13:27 UTC
-
Stress relief: could a simple steroid boost help PMR and GCA patients feel better?
Symptom relief Recruiting nowThis study tests whether taking extra hydrocortisone during times of stress (like illness or emotional strain) can improve quality of life, especially fatigue, in people with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA) who are already on low-dose prednisolone. Abou…
Matched conditions: GIANT CELL ARTERITIS
Phase: PHASE4 • Sponsor: Marianne Christina Klose • Aim: Symptom relief
Last updated Jun 15, 2026 19:06 UTC
-
DNA hunt for vasculitis genes opens new doors
Knowledge-focused Recruiting nowThis study collects DNA samples and medical information from 1,000 people with various forms of vasculitis (blood vessel inflammation). Researchers will analyze the data to identify genes that increase the risk of developing these severe diseases. The goal is to better understand…
Matched conditions: GIANT CELL ARTERITIS
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:52 UTC
-
Ultrasound clues may forecast arteritis relapses
Knowledge-focused Recruiting nowThis study looks at whether ultrasound images of the temporal and axillary arteries can help predict when giant cell arteritis (GCA) will flare up again. Researchers will follow 100 people with GCA to see if certain ultrasound patterns are linked to relapses. The goal is to impro…
Matched conditions: GIANT CELL ARTERITIS
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:05 UTC
-
MRI could replace biopsy for diagnosing dangerous artery inflammation
Knowledge-focused Recruiting nowThis study tests whether MRI scans can detect inflammation in the arteries of the head, brain, and eyes in people with suspected giant cell arteritis (GCA). Researchers will enroll 400 adults aged 50 and older with new or worsening symptoms and high inflammation levels. The goal …
Matched conditions: GIANT CELL ARTERITIS
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:55 UTC
-
400 patients tracked for hidden heart and steroid risks in common inflammatory diseases
Knowledge-focused Recruiting nowThis study follows 400 adults with giant cell arteritis or polymyalgia rheumatica to see how often serious aortic problems (like aneurysms) and steroid-related side effects occur over time. Researchers will track these events using medical records and a special steroid toxicity s…
Matched conditions: GIANT CELL ARTERITIS
Sponsor: Wuerzburg University Hospital • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:09 UTC
-
Tissue bank could unlock secrets of rare blood vessel diseases
Knowledge-focused Recruiting nowThis study gathers existing tissue samples from 1,000 people with various forms of vasculitis, a group of rare diseases that cause blood vessel inflammation. Researchers will analyze the tissue alongside medical data to find genes linked to the disease. The goal is to better unde…
Matched conditions: GIANT CELL ARTERITIS
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:09 UTC
-
Yale launches massive rheumatic disease data bank to unlock new treatments
Knowledge-focused Recruiting nowThis study is building a large registry and biorepository of 5000 adults with various rheumatic diseases like rheumatoid arthritis and lupus. Researchers will collect medical information and biological samples over time to identify patterns and biomarkers. The goal is to better u…
Matched conditions: GIANT CELL ARTERITIS
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 11, 2026 11:57 UTC
-
Massive study aims to unlock mysteries of rare blood vessel disease
Knowledge-focused Recruiting nowThis study follows up to 4,000 people with vasculitis (a group of diseases that cause blood vessel inflammation) and healthy volunteers over many years. Researchers collect blood, urine, imaging, and genetic samples to learn how the disease develops and changes. The goal is to fi…
Matched conditions: GIANT CELL ARTERITIS
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Jun 01, 2026 18:04 UTC